Swiss pharmaceutical firm lets dogs die cruel death
Young beagles are being used for cruel animal experiments and left to die in a German laboratory working for a Swiss pharma firm, says the report. (Screenshot from SRF footage)
SRF-SWI
Dogs are being left to die in agony in Germany after lab testing for the Swiss pharma company Inthera Bioscience, reports Swiss public television, SRF.
The dogs are young beagles, who are given high doses of substances for experiments on behalf of the Swiss biotech company, according to SRF. They are then left to die in agony with no care.
The report carries disturbing photos by an employee of the animal protection organisation Soko Tierschutz. This employee got himself hired as a carer in the LPTExternal link animal testing laboratory in Hamburg, and documented for several months what was happening there, says the report.
The pictures show tubes being inserted into a dog’s stomach and a test substance injected to find the dose at which severe side effects including death occur. The scenes show how the dogs suffer unnecessarily before their death, as they are left to die in agony.
SRF says that the laboratory is violating international welfare regulations and that such proceedings would not be permitted in Switzerland.
It quotes Friedrich Mülln of Soko Tierschutz as saying that such experiments are easier to carry out in Germany. “It is cheaper and the authorisation is simpler,” he says.
Asked for a response, Swiss firm Inthera Bioscience wrote that the authorities have approved all tests but that the company would suspend further cooperation with the service provider, LPT, until it had a “clear picture of the situation”.
LPT declined to answer specific questions but said such experiments were within the law and that its treatment of animals had never been questioned. An investigation into the service provider’s practices has been opened by the competent authorities following these findings, says SRF.
More
More
Stats show fewer animal experiments
This content was published on
Animal testing dropped by around 5% in 2018, latest figures show.
This content was published on
The Ethos Foundation recommends that shareholders vote against all compensation-related items at the Annual General Meeting on March 7.
Top Swiss firms close to reaching gender quota in boards
This content was published on
The proportion of women on the boards of directors of the fifty largest listed companies in Switzerland currently stands at 28%.
Swiss committee wants to end government resignations during legislative term
This content was published on
Members of the Federal Council should no longer be able to leave office before the end of their term, according to a House of Representatives committee.
Swiss government seat: Ritter and Pfister nominated to succeed Amherd
This content was published on
Markus Ritter from St Gallen and Martin Pfister from Zug were officially nominated by the Centre Party on Friday to succeed Defence Minister Viola Amherd.
Top Swiss court rejects Russian request for administrative tax assistance
This content was published on
There is currently no reason to transmit banking information to the Russian Federation, the Swiss Federal Court has ruled.
After strike by radiologists, doctors demonstrate in Bern
This content was published on
Following a strike by radiology technicians in Fribourg, doctors, vets, dentists and chiropractors expressed their frustration on Friday outside parliament in the Swiss capital.
Should journalists be more critical of research involving animals?
This content was published on
An anti-animal testing advocate and a science journalist address the Swiss media’s role in the debate over research involving animals.
This content was published on
The Swiss authorities have registered a major increase in militant animal rights activities last year, according to a newspaper report.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.